Andrea Mattevi Selected Research

Andrea Mattevi Research Topics

Disease

14	Neoplasms (Cancer) 07/2022 - 05/2010
5	Leukemia 01/2020 - 05/2010
2	Acute Promyelocytic Leukemia 01/2020 - 05/2010
2	Tuberculosis (Tuberculoses) 01/2017 - 09/2012
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2016 - 11/2012
2	Virus Diseases (Viral Diseases) 10/2014 - 05/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2011 - 12/2005
2	Trimethylaminuria 11/2010 - 05/2008
2	Hemolytic Anemia 04/2005 - 06/2002
2	Nervous System Diseases (Neurological Disorders) 04/2004 - 01/2002
1	Fibrosis (Cirrhosis) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Heart Diseases (Heart Disease) 01/2017
1	Intellectual Disability (Idiocy) 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 06/2014
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Treatment-Resistant Depressive Disorder 11/2011
1	Parkinson Disease (Parkinson's Disease) 11/2011
1	Caliciviridae Infections 08/2010
1	Infections 08/2010
1	Carcinogenesis 05/2010
1	Pathologic Processes 05/2010
1	type 3 Rhizomelic chondrodysplasia punctata 06/2007
1	Peroxisomal Disorders (Peroxisomal Disorder) 06/2007
1	Hemolysis 04/2005
1	Anemia 06/2002
1	Glucosephosphate Dehydrogenase Deficiency 06/2002

Drug/Important Bio-Agent (IBA)

7	Monoamine Oxidase (MAO)IBA 01/2017 - 01/2002
7	Pharmaceutical PreparationsIBA 01/2017 - 01/2002
6	Histone DemethylasesIBA 07/2022 - 05/2010
5	EnzymesIBA 01/2020 - 04/2005
4	Ether (Diethyl Ether)IBA 02/2019 - 06/2007
4	Biological ProductsIBA 01/2019 - 05/2008
3	Lysine (L-Lysine)FDA Link 01/2020 - 01/2016
3	Phospholipids (Phosphatides)FDA LinkGeneric 02/2019 - 06/2007
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2004
2	Tranylcypromine (Parnate)FDA LinkGeneric 01/2020 - 04/2015
2	Phosphates (Orthophosphate)IBA 02/2019 - 11/2015
2	LipidsIBA 02/2019 - 11/2015
2	Oxidoreductases (Dehydrogenase)IBA 06/2014 - 12/2005
2	Neurotransmitter Agents (Neurotransmitter)IBA 12/2005 - 04/2004
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2020
1	Cadherins (E-Cadherin)IBA 02/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2019
1	CTP synthetaseIBA 01/2017
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2017
1	Phospholipid EthersIBA 12/2016
1	Histones (Histone)IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2015
1	EicosanoidsIBA 11/2015
1	Glycerophospholipids (Phosphoglycerides)IBA 11/2015
1	N- ((5- (3- (1- benzylpiperidin- 4- yl)propoxy)- 1- methyl- 1H- indol- 2- yl)methyl)- N- methylprop- 2- yn- 1- amineIBA 06/2014
1	Cholinesterases (Cholinesterase)IBA 06/2014
1	Androgen Receptors (Androgen Receptor)IBA 01/2014
1	2- (2- methyl- 1,4- dioxa- 8- azaspiro(4.5)dec- 8- yl)- 8- nitro- 6- (trifluoromethyl)- 4H- 1,3- benzothiazin- 4- oneIBA 09/2012
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 11/2011
1	CatecholaminesIBA 11/2011
1	CytochromesIBA 11/2011
1	safinamideIBA 11/2011
1	Glutamic Acid (Glutamate)FDA Link 11/2011
1	Antiviral Agents (Antivirals)IBA 08/2010
1	ChromatinIBA 05/2010
1	dimethylaniline monooxygenase (N-oxide forming) (flavin-containing monooxygenase)IBA 05/2008
1	alkylglycerone-phosphate synthaseIBA 06/2007
1	5'-Nucleotidase (5' Nucleotidase)IBA 04/2005
1	Mutant Proteins (Protein, Mutant)IBA 06/2002
1	IsoenzymesIBA 06/2002

Therapy/Procedure

3	Therapeutics 01/2017 - 11/2011
1	Immunomodulation 01/2020
1	Oral Administration 02/2016